Dr. Amarinder Singh Thind is a Senior Research Bioinformatician and Causal Academic at the University of Sydney (USyd), Australia, and holds an honorary affiliation with the University of Wollongong (UOW). His expertise spans bioinformatics, biostatistics, and multi-omics data science, with a focus on developing computational/AI methods and integrating large-scale clinical and Health datasets to advance disease biology, biomarker discovery, and precision medicine.

Dr. Thind has collaborated with multidisciplinary teams across leading academic, clinical, and healthcare institutions, including the University of Sydney (USyd), Royal Prince Alfred Hospital (RPA), Stanford University, NSW Health, and the National University of Singapore (NUS). Working alongside clinicians, molecular biologists, geneticists, pathologists, and biostatisticians, he has contributed to research spanning cancer genomics, transcriptomics, proteomics, spatial omics, clinical informatics, and precision medicine.

His research aim is to harness integrative multi-omics, and advanced statistical modelling to better understand the molecular mechanisms underlying complex diseases particularly cancer and to translate these discoveries into clinically meaningful biomarkers and therapeutic strategies. By developing  computational frameworks and fostering interdisciplinary collaborations, he aims to bridge the gap between multi-omics data and clinical decision-making, enabling more accurate diagnosis, patient stratification, and personalised treatment.

Dr. Thind is particularly interested in building computational methods that are not only scientifically rigorous but also readily applicable in clinical and translational research, accelerating the adoption of data-driven precision oncology and improving patient outcomes.